Drawing for UROBIOTX

USPTO serial 98811735

UROBIOTX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ROACH, APRIL K
Law office
TMO LAW OFFICE 115

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with UROBIOTX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ANDREW LANGSAM

ANDREW LANGSAM Law Office of Andrew S. Langsam PLLC28 Limestone RoadArmonk, NY 10504United States

Goods and services

ClassDescriptionStatusFirst use
003cleaning agents and preparations; cleaning preparations with a solvent base; cleaning solvents, other than for use in manufacturing processes; cleaning preparations; preparations for cleaning surfaces; cleaning and washing preparations and substancesACTIVE—
005disinfectants for veterinary use; disinfectants for veterinary purposes; disinfectants for agricultural purposes; all purpose disinfecting and deodorizing preparations; all-purpose disinfectants; all-purpose disinfecting and deodorizing preparations; antiviral disinfectants; disposable disinfectant wipes; disinfectants for medical use; disinfectants for medical or hygiene purposes; disinfectants for medical or hygiene use; disinfectants for medical instruments; disinfectants for hygiene purposes; disinfectants and antiseptics; disinfectants for medical apparatus and instruments; disinfectant wipes; wipes impregnated with disinfectants for hygiene purposes; disinfectants; disinfectants for medical purposes; disinfecting handwash; disinfecting hand wash; disinfectants for sanitary purposes; disinfectants for sanitary use; disinfectants for household use; household disinfectants; drugs for medical use, namely treatment or prevention of pathologies of the urinary system; drugs for medical purposes, namely treatment or prevention of pathologies of the urinary system; medicines for human purposes, namely treatment or prevention of pathologies of the urinary system ; medicines for human use, namely treatment or prevention of pathologies of the urinary system; pharmaceutical drugs, namely for treatment or prevention of pathologies of the urinary system; pharmaceuticals, namely for treatment or prevention of pathologies of the urinary system; chemicals for medical use, namely for treatment or prevention of pathologies of the urinary system; chemicals for medical purposes, namely for treatment or prevention of pathologies of the urinary system; pharmaceutical substances, namely for treatment or prevention of pathologies of the urinary system; pharmaceutical products, namely for treatment or prevention of pathologies of the urinary system, for use by humans; medicines for veterinary purposes, namely for treatment or prevention of pathologies of the urinary system; therapeutic drugs and agents, namely for treatment or prevention of pathologies of the urinary system; biochemical medicines, namely for treatment or prevention of pathologies of the urinary system; medicines, namely for treatment or prevention of pathologies of the urinary system; herbal medicines, namely for treatment or prevention of pathologies of the urinary system; pharmaceutical and medical preparations, namely for treatment or prevention of pathologies of the urinary system; medicinal substances and preparations, namely for treatment or prevention of pathologies of the urinary system; medicinal healthcare preparations, namely for treatment or prevention of pathologies of the urinary system; pharmaceuticals, medical and veterinary preparations, namely for treatment or prevention of pathologies of the urinary system; pharmaceutical substances and preparations, namely for treatment or prevention of pathologies of the urinary system; medicinal health care preparations, namely for treatment or prevention of pathologies of the urinary system; pharmaceutical preparations for health care, namely for treatment or prevention of pathologies of the urinary system; herbal preparations for use in medicine, namely for treatment or prevention of pathologies of the urinary system; medicinal drinks; dietary food supplements and substances being for treatment or prevention of pathologies of the urinary system; dietary supplements for medical use; food supplements for medical use; dietary food supplements and substances being for treatment or prevention of pathologies of the urinary system; homeopathic medicines for treatment or prevention of pathologies of the urinary system; disinfectant soaps; disinfectant washes other than soaps; disinfecting perfumed soap.ACTIVE—
042scientific research for medical purposes; scientific research services for medical purposes; biological research services; medical research laboratory services; scientific research and development; scientific research in the field of urinary system pathologies; research in the field of chemistry; bacteriological research and analysis; biological research and analysis in the field of urinary system pathologies; research laboratories, namely medical research laboratories in the field of urinary system pathologies; scientific research and analysis related to urinary system pathologies; biological research; clinical research in the field of urinary system pathologies; medical research; medical research laboratories; research to develop new products for others; biological research, clinical research in the field of urinary system pathologies and medical research; medical research and development of medicinal preparations to understand, treat and prevent pathologies of the urinary system; scientific and medical research and development of medicinal preparations, namely to treat and prevent pathologies of the urinary system; biological, medical research and clinical research in the field of urinary system pathologies; research and development of medicines; biotechnological research; research and development in the field of biomedicine; scientific research; research in the field of chemistry; scientific research in the field of chemistry; chemistry research; research in the fields of chemistry and biology; research in the field of biochemistry; bacteriological research and testing; research relating to bacteriology; scientific research relating to bacteriology; research in the field of bacteriology; research and development in the field of biotechnology; research in the field of biotechnology; scientific research in the field of biotechnology; research relating to biotechnology; biotechnology research; medical research services; scientific research and development services and medical research and development in the field of urinary system pathologies; biomedical research; biomedical research servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Nov 18, 2025MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 18, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 4, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 26, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 26, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 26, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 25, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 18, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 18, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 21, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 1, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2025DOCKASSIGNED TO EXAMINER—
Oct 22, 2024TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Oct 22, 2024PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 21, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 21, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance